ESC Premium Access

The role of statins in patients with heart failure with preserved, mid-range and reduced ejection fraction; a meta-analysis and systematic review

Congress Presentation

About the speaker

Professor Agata Magdalena Bielecka-Dabrowa

Medical University of Lodz, Lodz (Poland)
0 follower

3 more presentations in this session

Predictive value of diastolic dysfunction severity on long-term survival in heart failure patients with mid-range or reduced left ventricular ejection fraction

Speaker: Doctor K. Hu (Wuerzburg, DE)


Functional behavior of heart failure with mid-range ejection fraction assessed by stress echocardiography and cardiopulmonary exercise test: truly distinctive phenotype o simply mid-way entity?

Speaker: Doctor M. Barletta (Milan, IT)


Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? - from the ESC-HF Long-Term Registry

Speaker: Doctor A. Kaplon Cieslicka (Warsaw, PL)


Access the full session

Heart failure with mid-range ejection fraction: the controversy continues

Speakers: Professor A. Bielecka-Dabrowa, Doctor K. Hu, Doctor M. Barletta, Doctor A. Kaplon Cieslicka

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb